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Background
Mucosal administration of vaccine candidate is a chal-
lenging strategy to induce protective HIV immune
responses at portal of entry. For instance, mechanisms
involved in the uptake of synthetic particulate vehicles of
vaccination such as poly(lactic acid) (PLA) nanoparticles
need to be defined. Our approach aims to target intestinal
mucosa, and we used fluorescent PLA nanoparticles to
decipher the mechanisms of their fate and transport
through mucosal barrier.
Methods
Two fluorophores, 6-coumarin or CellTrace BODIPY,
were incorporated within the core of PLA nanoparticles,
synthesized by solvent diffusion method. Physico-chemi-
cal properties of green or red fluorescent particles were
analyzed and compared with blank PLA particles (without
fluorophore). We have used mice ilea ligated loop to
mimic as closely as possible the trafficking of our nano-
particles in the intestinal physiological conditions. The
transport of nanoparticles through the epithelium was fol-
lowed by confocal fluorescent microscopy. The colocalisa-
tion of nanoparticles with M-cells, enterocytes and goblet
cells was observed by specific lectins labelling. Further-
more, the fate of particles in the sub-epithelial dome was
analyzed by flow cytometry, after enzymatic digestion of
Peyer's patches.
Results
The fluorescent PLA nanoparticles penetrated the intesti-
nal mucosa preferentially in the Peyer's patches area.
Moreover, these nanoparticles crossed the epithelium
mainly via M-cells, which are specialized cells in antigen
transport from the lumen to the underlying dendritic
cells. Thus, the fate of PLA nanoparticles was followed in
the sub-epithelial dome, using the technique of flow
cytometry, and revealed the specific uptake of particles by
dendritic cells and by B cells.
Conclusion
Our findings suggest the appropriate crossing of PLA nan-
oparticles trough the intestinal barriers and their delivery
to the antigen presenting cells of the lamina propria of the
Peyer's patches. This cellular specific uptake in intestine is
promising for the delivery of HIV antigens associated to
PLA particles in the field of mucosal vaccination.
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